Drug profile · INN
olipudase alfa-rpcp
XENPOZYME
olipudase alfa-rpcp (XENPOZYME) is a sphingomyelin hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Drug details — olipudase alfa-rpcp
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
olipudase alfa-rpcp (XENPOZYME) is a sphingomyelin hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Sphingomyelin hydrolytic enzyme
Primary target: Sphingomyelin
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is olipudase alfa-rpcp?
olipudase alfa-rpcp (XENPOZYME) is a sphingomyelin hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for olipudase alfa-rpcp?
XENPOZYME is a marketed brand name for olipudase alfa-rpcp. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of olipudase alfa-rpcp?
olipudase alfa-rpcp has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.